<DOC>
	<DOCNO>NCT02493764</DOCNO>
	<brief_summary>This study aim compare treatment imipenem/relebactam/cilastatin ( IMI/REL ) fixed-dose combination ( FDC ) piperacillin/tazobactam ( PIP/TAZ ) FDC participant hospital-acquired ventilator-associated bacterial pneumonia . The primary hypothesis IMI/REL non-inferior PIP/TAZ incidence rate all-cause mortality .</brief_summary>
	<brief_title>Imipenem/Relebactam/Cilastatin Versus Piperacillin/Tazobactam Treatment Participants With Bacterial Pneumonia ( MK-7655A-014 )</brief_title>
	<detailed_description />
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Pneumonia , Bacterial</mesh_term>
	<mesh_term>MK-7655</mesh_term>
	<mesh_term>Tazobactam</mesh_term>
	<mesh_term>Piperacillin , tazobactam drug combination</mesh_term>
	<mesh_term>Penicillanic Acid</mesh_term>
	<mesh_term>Piperacillin</mesh_term>
	<mesh_term>Linezolid</mesh_term>
	<mesh_term>Imipenem</mesh_term>
	<mesh_term>Cilastatin</mesh_term>
	<criteria>Requires treatment IV antibiotic therapy hospitalacquired bacterial pneumonia ( HABP ) ventilatorassociated bacterial pneumonia ( VABP ) Fulfills clinical radiographic criterion , onset criterion occur 48 hour hospitalization within 7 day discharge hospital ( HABP ) ; least 48 hour mechanical ventilation ( VABP ) Has adequate baseline lower respiratory tract specimen obtain Gram stain culture Has infection know thought cause microorganisms susceptible IV study therapy Agrees allow bacterial isolates obtain protocolrequired specimen related current infection provide Central Microbiology Reference Laboratory studyrelated microbiological testing , long term storage , future testing Is reproductive potential ; reproductive potential agree avoid impregnate partner avoid become pregnant , practice abstinence use acceptable contraception Has baseline low respiratory tract specimen Gram stain show presence Grampositive cocci Has confirm suspect communityacquired bacterial pneumonia ( CABP ) Has confirm suspect pneumonia viral , fungal parasitic origin Has HABP/VABP cause obstructive process , include lung cancer know obstruction Has carcinoid tumor carcinoid syndrome Has active immunosuppression define either receive immunosuppressive medication medical condition associate immunodeficiency Is expect survive less 72 hour Has concurrent condition infection would preclude evaluation therapeutic response Has receive effective antibacterial drug therapy index infection HABP/VABP 24 hour continuously , previous 72 hour Has history serious allergy , hypersensitivity serious reaction penicillin betalactamase inhibitor Female pregnant , expect conceive , breastfeed plan breastfeed Has history seizure disorder require ongoing prior treatment anticonvulsive therapy within last 3 year Anticipates treatment follow : valproic acid divalproex sodium , serotonin reuptake inhibitor , tricyclic antidepressant , serotonin receptor antagonist , meperidine , buspirone , concomitant systemic antibacterial agent , antifungal antiviral therapy index infection HABP/VABP Is currently undergoing hemodialysis peritoneal dialysis Is currently participate , participate previous 30 day , anticipate participate clinical study involve administration experimental medication Has previously participate study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>